Trial Profile
A phase III trial of somavartan in adults with growth hormone deficiency
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 11 Jan 2019
Price :
$35
*
At a glance
- Drugs Somavaratan (Primary)
- Indications Somatotropin deficiency
- Focus Therapeutic Use
- Acronyms VITAL
- 08 Mar 2017 New trial record
- 02 Mar 2017 This trial is expected to begin by the end of 2017, according to a Versartis media release.